
Heart diseases are the number one cause of death worldwide, but still remains underexplored when it comes to new drugs. INTEC aims at creating the next generation of screening solutions that will enable new insights into cardiac disease mechanics and provide means to increase drug development efficiency.

Cardiac diseases is the leading cause of death worldwide but is underrepresented among newly approved drugs, largely due to lack of predictive human disease models. INTEC aims at providing a solution.

The INTEC project combines high precision microfluidics, single-cell high-content cardicac contractility systems and advanced functional analysis to create next generation cardiac screening solutions.

INTEC brings together a team of screening technology experts, comining Fluicell’s unique single-cell microfluidic technology with Cytocypher’s advanced cardiac analysis solutions.